Wolfgang Hofmann
Chief Executive Officer Leon-Nanodrugs GmbH
Seminars
Wednesday 8th April 2026
Panel Discussion: Overcoming Clinical Bottlenecks in LNP Development by Streamlining Processes for Advancing Safer Drug Products to Patients
10:00 am
- What are the most crucial technical challenges in translating LNP formulations from preclinic to human studies?
- As the field moves from early clinical programs to commercialization, what are the key challenges in translating LNP formulations from small-scale development into robust, large-scale manufacturing processes?
- How to optimize the dosing strategies for LNPs to ensure safe and effective therapeutics?
